3GF-16018-27589

2 vaccinations 8 coded responses 24 check-ins 8 free-text entries 1 call case

Sex: Female
Age at first dose: 26-30
ZIP prefix: 605 / IL
Registered: 2021-03-23

Relationship: Self
Race: White
Ethnicity: Not Hispanic or Latino

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-22
Dose 1 — Pfizer-BioNTech
2021-03-23
Registered in v-safe
2021-03-23
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness

Adult check-in
2021-03-24
Survey response — days 1–6 daily, dose 1
MedDRA: Hypoacusis, Lymphadenopathy, Respiratory tract congestion — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Fatigue or tiredness · Be unable to do your normal daily activities

Free text: Swollen lymph nodes under armpit, congestion, difficulty hearing from one ear

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-25
Survey response — days 1–6 daily, dose 1
MedDRA: Deafness, Lymphadenopathy, Respiratory tract congestion — Feeling: Fair · Site: Pain · Headache

Free text: Swelling in lymph nodes in armpits, congestion/difficulty hearing in one ear

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-26
Survey response — days 1–6 daily, dose 1
MedDRA: Lymphadenopathy, Respiratory tract congestion — Feeling: Fair · Headache

Free text: Some congestion and swelling of lymph node under armpit

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-27
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Swelling · Headache, Fatigue or tiredness

Adult check-in
2021-03-28
Survey response — days 1–6 daily, dose 1
MedDRA: Respiratory tract congestion — Feeling: Good · Headache

Free text: Congestion

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-29
Health check-in — day 7, dose 1
Feeling: Good · Headache

Adult check-in
2021-04-05
Health check-in — day 14, dose 1
Feeling: Fair

Adult check-in
2021-04-12
Dose 2 — Pfizer-BioNTech
2021-04-12
Health check-in — day 0, dose 2
Feeling: Good · Site: Pain · Headache

Adult check-in
2021-04-13
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain, Redness, Swelling · Fever · Headache, Fatigue or tiredness, Nausea

Adult check-in
2021-04-14
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Headache, Fatigue or tiredness, Nausea

Adult check-in
2021-04-15
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain, Swelling, Itching · Headache, Fatigue or tiredness, Nausea

Adult check-in
2021-04-16
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain, Swelling, Itching · Headache, Fatigue or tiredness, Nausea

Adult check-in
2021-04-17
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · None

Adult check-in
2021-04-18
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Itching · Headache, Fatigue or tiredness

Adult check-in
2021-04-19
Health check-in — day 7, dose 2
Feeling: Good · Site: Itching · Headache

Adult check-in
2021-04-26
Survey response — day 14, dose 2
MedDRA: Head discomfort, Tinnitus — Feeling: Fair

Free text: Head congestion and ringing in ears

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-03
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-05-12
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-05-17
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-05-24
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-07-12
Survey response — 3 months, dose 2
MedDRA: Eye disorder, Migraine, Optic nerve injury — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Currently investigating eye-related issue impacting my optic nerve as well as some migraines

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-10-11
Survey response — 6 months, dose 2
MedDRA: Dry eye, Migraine, Tension headache — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Migraines, eye dryness, tension headaches

MedDRA releases: 2024-11 · check-in free text available
2022-04-12
Survey response — 12 months, dose 2
MedDRA: Gastrointestinal disorder, Hypersensitivity, Migraine — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit

Free text: GI issues, development of new allergies, migraines

MedDRA releases: 2024-11 · check-in free text available
2022-04-12
Report sent to call center — 12 months, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-04-15
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-22	Pfizer-BioNTech
2	2021-04-12	Pfizer-BioNTech

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 6 — days 1–6 daily, dose 1

2021-03-24

Systemic reaction (other): Swollen lymph nodes under armpit, congestion, difficulty hearing from one ear

2021-03-25

Systemic reaction (other): Swelling in lymph nodes in armpits, congestion/difficulty hearing in one ear

2021-03-26

Systemic reaction (other): Some congestion and swelling of lymph node under armpit

2021-03-28

Systemic reaction (other): Congestion

Release 8 — day 14, dose 2

2021-04-26

Symptoms: Head congestion and ringing in ears

Release 9 — 3 months, dose 2

2021-07-12

Symptoms: Currently investigating eye-related issue impacting my optic nerve as well as some migraines

Release 10 — 6 months, dose 2

2021-10-11

Symptoms: Migraines, eye dryness, tension headaches

Release 11 — 12 months, dose 2

2022-04-12

Symptoms: GI issues, development of new allergies, migraines

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Dry eye	·	·	✓
SD	Eye disorder	✓	✓	✓
SD	Gastrointestinal disorder	·	·	✓
SD	Head discomfort	✓	✓	✓
SD	Hypersensitivity	·	·	✓
SD	Migraine	✓	✓	✓
SD	Optic nerve injury	✓	✓	✓
SD	Tension headache	·	·	✓
SD	Tinnitus	✓	✓	✓
SRO	Deafness	✓	✓	✓
SRO	Hypoacusis	✓	✓	✓
SRO	Lymphadenopathy	✓	✓	✓
SRO	Respiratory tract congestion	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release